Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H27NO |
Molecular Weight | 285.4238 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(N1CCCC1)C(=O)C2=CC3=C(CCCC3)C=C2
InChI
InChIKey=MMIKQWIZKBYLKZ-UHFFFAOYSA-N
InChI=1S/C19H27NO/c1-2-7-18(20-12-5-6-13-20)19(21)17-11-10-15-8-3-4-9-16(15)14-17/h10-11,14,18H,2-9,12-13H2,1H3
Molecular Formula | C19H27NO |
Molecular Weight | 285.4238 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:16:59 GMT 2023
by
admin
on
Sat Dec 16 10:16:59 GMT 2023
|
Record UNII |
S5MU9GV87C
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-TH-PVP
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID201337111
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY | |||
|
CYCLOHEXANE-.ALPHA.-PVP
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY | |||
|
TH-PVP
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY | |||
|
132989549
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY | |||
|
S5MU9GV87C
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY | |||
|
TH-PVP
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY | |||
|
2304915-07-7
Created by
admin on Sat Dec 16 10:16:59 GMT 2023 , Edited by admin on Sat Dec 16 10:16:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Inhibition of [125I]RTI-55 binding Ki ± sem (μΜ) (n)
Ki
|
||
|
TARGET -> INHIBITOR |
nhibition of [3H]neurotransmitter uptake IC50 ± sem (μΜ).
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Pharmacological studies in vitro showed it to inhibit reuptake and promote the release of monoamine neurotransmitters with some selectivity for serotonin,
|